Colonial Trust CO / Sc Moderna, Inc. Transaction History

Colonial Trust CO / Sc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$23.65 - $28.54 $662 - $799	-28 Reduced 8.24%	312 $8,000
Q1 2025 May 13, 2025	BUY	$28.35 - $47.53 $708 - $1,188	25 Added 7.94%	340 $9,000
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $331 - $575	9 Added 2.94%	315 $13,000
Q3 2024 Nov 12, 2024	BUY	$63.64 - $125.14 $381 - $750	6 Added 2.0%	306 $20,000
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $170 - $230	-2 Reduced 0.66%	300 $31,000

Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $2,293 - $3,446	-33 Reduced 9.85%	302 $30,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $3,374 - $4,431	35 Added 11.67%	335 $34,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $35,514 - $63,012	300 New	300 $53,000

845

257M

39.6M

43.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

Stay updated on Colonial Trust CO / Sc with notifications on news.